Steve Trokenheim on disclosing drug list prices in advertisements

Share on facebook
Share on twitter
Share on linkedin

Pharma companies may be regulated to publicize drug prices in advertisements, but sharing only the drug’s list price can be misleading. Pharma companies should share context such as a drug’s typical out-of-pocket costs, efficacy, safety and dosing convenience to help patients make informed decisions. Partner Steve Trokenheim explains how pharma companies can educate physicians and patients on the full context of a drug’s value.